Company”) would like to report the operating results of the Company and its subsidiaries for the second quarter of 2020, ended June 30, 2020 as follows: Statement of comprehensive income Statement of
Company”) would like to report the operating results of the Company and its subsidiaries for the third quarter of 2020, ended September 30, 2020 as follows: Statement of profit or loss Statement of profit
Total Income 2. Expenses 2.1 Expenses on Borrowing 2.2 Fee and Service Expenses 2.3 Bad debt and doubtful accounts 2.4 Shares of loss of subsidiaries and affiliated 2.5 Operating expenses 2.5.1 Personnel
subsidiaries and affiliated 2.5 Operating expenses 2.5.1 Personnel expenses 2.5.2 Premises and equipment expenses 2.5.3 Taxes and duties 2.5.4 Directors’ remuneration 2.5.5 Others expenses Total Expenses
Shares of loss of subsidiaries and affiliated 2.5 Operating expenses 2.5.1 Personnel expenses 2.5.2 Premises and equipment expenses 2.5.3 Taxes and duties 2.5.4 Directors’ remuneration 2.5.5 Others
their operating costs, transfer fee of drug registration to be paid to government agencies that should be responsible by seller บร ิษัท อ ินเตอร ์ฟารม์า จาํกัด (มหาชน) เลขท ี / อาคารไอทเีอฟ ชัน ถนนสีลม
disposed percentage, divided by net profit of the Company Calculation cannot be made given each of the Company, UAB and SBM has operating losses n.a. 3. Total consideration Total consideration paid or
คำอธิบายและการวิเคราะห์ของฝ่ายจัดการ 28 February 2020 Re: To clarify the financial statements as of 31 December 2019 To: President The Stock Exchange of Thailand As WHA Corporation Public Company
, an increase of 64.46 million baht or 305.84% of the net profit for the same period last year. This was due to the better operating results of the subsidiaries Net profit for Q2 / 2020 was 55.27 million